SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-077613
Filing Date
2024-03-26
Accepted
2024-03-26 16:14:59
Documents
14
Period of Report
2024-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812258d8k.htm   iXBRL 8-K 25798
2 EX-99.1 d812258dex991.htm EX-99.1 46415
  Complete submission text file 0001193125-24-077613.txt   211893

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krro-20240326.xsd EX-101.SCH 2893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krro-20240326_lab.xml EX-101.LAB 19501
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krro-20240326_pre.xml EX-101.PRE 12185
18 EXTRACTED XBRL INSTANCE DOCUMENT d812258d8k_htm.xml XML 4024
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 24783693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)